Cargando…
Natural products as new antimitotic compounds for anticancer drug development
Cell cycle control genes are frequently mutated in cancer cells, which usually display higher rates of proliferation than normal cells. Dysregulated mitosis leads to genomic instability, which contributes to tumor progression and aggressiveness. Many drugs that disrupt mitosis have been studied beca...
Autores principales: | Paier, Carlos Roberto Koscky, Maranhão, Sarah Sant'Anna, Carneiro, Teiliane Rodrigues, Lima, Lídia Moreira, Rocha, Danilo Damasceno, da Silva Santos, Renan, de Farias, Kaio Moraes, de Moraes-Filho, Manoel Odorico, Pessoa, Claudia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6256996/ https://www.ncbi.nlm.nih.gov/pubmed/30540125 http://dx.doi.org/10.6061/clinics/2018/e813s |
Ejemplares similares
-
Genomic surveillance: Circulating lineages and genomic variation of SARS-CoV-2 in early pandemic in Ceará state, Northeast Brazil
por: Oliveira, Francisca Andréa da Silva, et al.
Publicado: (2022) -
Photopharmacology of Antimitotic Agents
por: Kirchner, Susanne, et al.
Publicado: (2022) -
The Role of WRAP53 in Cell Homeostasis and Carcinogenesis Onset
por: Gadelha, Renan Brito, et al.
Publicado: (2022) -
Antimitotic drugs in the treatment of cancer
por: van Vuuren, Rustelle Janse, et al.
Publicado: (2015) -
Pharmacokinetic Profile Evaluation of Novel Combretastatin Derivative, LASSBio-1920, as a Promising Colorectal Anticancer Agent
por: Guimarães, Celina de Jesus, et al.
Publicado: (2023)